Therefore, we suggest that CTE improves AD symptoms by complexly regulating multiple factors related to AD pathology, including chemokine secretion from keratinocytes, TSLP, IL-4, and ICAM-1 expression in lesions, and CD4+ T cell priming. Here, ICAM1 is linked to Alzheimer disease.